Commercial or communal: Why is outsourcing taboo for churches and pharmaceutical companies?
- Details
- Category: Research
Consumers hold churches and pharmaceutical companies to different moral standards than other organizations, according to a new study in the Journal of Consumer Research.
Scientists discover new way to target cancer
- Details
- Category: Research
Scientists have discovered a new way to target cancer through manipulating a master switch responsible for cancer cell growth. The findings, published in the journal Cancer Cell, reveal how cancer cells grow faster by producing their own blood vessels.
Mayo Clinic researchers find drug duo kills chemotherapy-resistant ovarian cancer cells
- Details
- Category: Research
The use of two drugs never tried in combination before in ovarian cancer resulted in a 70 percent destruction of cancer cells already resistant to commonly used chemotherapy agents, say researchers at Mayo Clinic in Florida.
Plasma-based treatment goes viral
- Details
- Category: Research
Life-threatening viruses such as HIV, SARS, hepatitis and influenza, could soon be combatted in an unusual manner as researchers have demonstrated the effectiveness of plasma for inactivating and preventing the replication of adenoviruses.
New Potential Personalized Medicine Platform
- Details
- Category: Research
p-medicine project, launched in February this year, is a 4-year Integrated project aiming at developing a new and state-of-the-art IT platform for personalized medicine. The researchers elaborated the first deliverables according to the agreed 'Description of Work', they identified and described motivated use case scenarios by underlining the p-medicine platform's end user needs and requirements.
Breakthrough in the battle against malaria
- Details
- Category: Research
An international team of scientists has announced a breakthrough in the fight against malaria, paving the way for the development of new drugs to treat the deadly disease. According to the World Health Organisation malaria currently infects more then 225 million people worldwide and accounts for nearly 800,000 deaths per year.
Researchers engineer blood stem cells to fight melanoma
- Details
- Category: Research
Researchers from UCLA's cancer and stem cell centers have demonstrated for the first time that blood stem cells can be engineered to create cancer-killing T-cells that seek out and attack a human melanoma.
More Pharma News ...
- Researchers discover clues to developing more effective antipsychotic drugs
- One adult in ten will have diabetes by 2030
- Vaccine for metastatic breast, ovarian cancer shows promise
- New study challenges accepted approaches to research in senile dementia
- 'Vampire' Bacteria Has Potential as Living Antibiotic
- Colorectal cancer drug may cause permanent nerve damage
- Genetically modified 'serial killer' T cells obliterate tumors in leukemia patients